These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38428579)

  • 21. [Methylphenidate. A possibility for rare hyperactive children].
    Rev Infirm; 2004 Sep; (103):39-40. PubMed ID: 15517803
    [No Abstract]   [Full Text] [Related]  

  • 22. The effect of methylphenidate on oppositional defiant disorder comorbid with attention deficit/hyperactivity disorder.
    Serra-Pinheiro MA; Mattos P; Souza I; Pastura G; Gomes F
    Arq Neuropsiquiatr; 2004 Jun; 62(2B):399-402. PubMed ID: 15273834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [All you need to know about methylphenidate (and dared not ask)].
    Zimmer L; Fourneret P
    Arch Pediatr; 2018 Apr; 25(3):229-235. PubMed ID: 29544968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbidities.
    Faraone SV
    Neurosci Biobehav Rev; 2018 Apr; 87():255-270. PubMed ID: 29428394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methylphenidate and intracortical excitability: opposite effects in healthy subjects and attention-deficit hyperactivity disorder.
    Moll GH; Heinrich H; Rothenberger A
    Acta Psychiatr Scand; 2003 Jan; 107(1):69-72. PubMed ID: 12558545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of stimulants on the continuous performance test (CPT): implications for CPT use and interpretation.
    Riccio CA; Waldrop JJ; Reynolds CR; Lowe P
    J Neuropsychiatry Clin Neurosci; 2001; 13(3):326-35. PubMed ID: 11514638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Attention deficit disorder with hyperactivity (ADHD). Continuing symptom control with medium term methylphenidate treatment].
    Oberpichler-Schwenk H
    Med Monatsschr Pharm; 2006 Nov; 29(11):415-6. PubMed ID: 17131689
    [No Abstract]   [Full Text] [Related]  

  • 28. Methylphenidate for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents.
    Storebø OJ; Simonsen E; Gluud C
    JAMA; 2016 May; 315(18):2009-10. PubMed ID: 27163989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of methylphenidate on neural systems of attention in attention deficit hyperactivity disorder.
    Shafritz KM; Marchione KE; Gore JC; Shaywitz SE; Shaywitz BA
    Am J Psychiatry; 2004 Nov; 161(11):1990-7. PubMed ID: 15514398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predicting methylphenidate response in attention deficit hyperactivity disorder: a preliminary study.
    Johnston BA; Coghill D; Matthews K; Steele JD
    J Psychopharmacol; 2015 Jan; 29(1):24-30. PubMed ID: 25237119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resveratrol adjunct to methylphenidate improves symptoms of attention-deficit/hyperactivity disorder: a randomized, double-blinded, placebo-controlled clinical trial.
    Rafeiy-Torghabeh M; Ashraf-Ganjouei A; Moradi K; Bagheri S; Mohammadi MR; Akhondzadeh S
    Eur Child Adolesc Psychiatry; 2021 May; 30(5):799-807. PubMed ID: 32449130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of methylphenidate and bupropion on DHEA-S and cortisol plasma levels in attention-deficit hyperactivity disorder.
    Lee MS; Yang JW; Ko YH; Han C; Kim SH; Lee MS; Joe SH; Jung IK
    Child Psychiatry Hum Dev; 2008 Jun; 39(2):201-9. PubMed ID: 17763937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. General anesthesia in a juvenile with attention-deficit hyperactivity disorder accompanied by long-term use of methylphenidate (Concerta).
    Chang CH; Yang CF; Huang YC; Tang GJ; Chan KH; Ting CK
    Acta Anaesthesiol Taiwan; 2009 Dec; 47(4):208-11. PubMed ID: 20015823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The development of selective attention in children with attention deficit hyperactivity disorder.
    Brodeur DA; Pond M
    J Abnorm Child Psychol; 2001 Jun; 29(3):229-39. PubMed ID: 11411785
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methylphenidate for children and adolescents with autism spectrum disorder.
    Sturman N; Deckx L; van Driel ML
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011144. PubMed ID: 29159857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Comparison of Effectiveness of Parent Behavioral Management Training and Methylphenidate on Reduction of Symptomsof Attention Deficit Hyperactivity Disorder.
    Mohammadi MR; Soleimani AA; Ahmadi N; Davoodi E
    Acta Med Iran; 2016 Aug; 54(8):503-509. PubMed ID: 27701720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of methylphenidate on motor performance and attention in children with developmental coordination disorder and attention deficit hyperactive disorder.
    Bart O; Daniel L; Dan O; Bar-Haim Y
    Res Dev Disabil; 2013 Jun; 34(6):1922-7. PubMed ID: 23584172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Counting Stroop Functional Magnetic Resonance Imaging Study on the Effects of ORADUR-Methylphenidate in Drug-Naive Children with Attention-Deficit/Hyperactivity Disorder.
    Shang CY; Chou TL; Hsieh CY; Gau SS
    J Child Adolesc Psychopharmacol; 2022 Nov; 32(9):467-475. PubMed ID: 36251766
    [No Abstract]   [Full Text] [Related]  

  • 39. Assessment of changes in the macula and optic nerve head using optical coherence tomography in patients with attention deficit hyperactivity disorder.
    Sánchez-Guillén I; Almorín-Fernández-Vigo I; Fernández-Vigo JI; de-Pablo-Gómez-de-Liaño L; Kudsieh B; Fernández-Vigo JA
    Arch Soc Esp Oftalmol (Engl Ed); 2020 Jun; 95(6):271-278. PubMed ID: 32423628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of methylphenidate on social cognition and oxytocin in children with attention deficit hyperactivity disorder.
    Levi-Shachar O; Gvirts HZ; Goldwin Y; Bloch Y; Shamay-Tsoory S; Zagoory-Sharon O; Feldman R; Maoz H
    Neuropsychopharmacology; 2020 Jan; 45(2):367-373. PubMed ID: 31514201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.